Lille 2005 - Société de Toxicologie Clinique
Documents pareils
Sessions scientifiques III, IV, V, VI Vendredi (p.m.), le 9 novembre 2012
symptoms improvement under intensive behavioural and medical (oxybutinin or tolterodine) therapies and/or significant S/E with other agents. The follow-up consisted of voiding diaries, post-void re...
Plus en détail